Search site Search ticker symbol

Are you looking for a stock?

Try one of these

News Tagged By: Pharmaceuticals

AbbVie to buy Shire for $54.8B for tax benefit

AbbVie Inc. agreed to buy Shire Plc for about 32 billion pounds ($54.8 billion US), becoming the latest U.S. health-care company to shift its tax residence abroad in a record surge in industry deals.

Posted on 7-18-2014 at 8:24 AM
Tags: Pharmaceuticals

Valeant looks for acquisitions to dodge taxes: Melnyk

This is the motive behind Valeant Pharmaceuticals International’s private equity-esq growth by acquisition strategy according to Biovail Corp. founder Eugene Melnyk.

Posted on 7-15-2014 at 4:17 PM
Tags: Valeant Pharmaceuticals, Jeff Lagerquist, Pharmaceuticals, M&A

When it comes to Valeant and Allergan, why not bet on both?

Valeant and hedge fund manager Bill Ackman continued their pursuit of botox maker Allergan this week. On Monday, Ackman’s hedge fund Pershing Square unveiled his slate of directors for Allergan’s...

Posted on 7-11-2014 at 5:04 PM
Tags: Allergan, Valeant Pharmaceuticals, Franklin Cameron, Pershing Square, Pharmaceuticals

Medtronic buys Covidien for $42.9B

There is a pretty big takeover being announced in the field of medical devices.

Posted on 6-16-2014 at 7:05 AM
Tags: Pharmaceuticals

Valeant raises takeover offer for Allergan for second time

Valeant Pharmaceuticals International Inc. raised its unsolicited offer for Allergan Inc. a second time, increasing the cash portion of the bid in an effort to win backing from the target and its...

Posted on 5-30-2014 at 3:18 PM
Tags: Valeant Pharmaceuticals, Allergan, Pharmaceuticals

Valeant hikes bid for Botox-maker Allergan to nearly $50B

Valeant Pharmaceuticals International Inc. is sweetening its unsolicited offer for Botox-maker Allergan Inc. (AGN.N) with a cash increase of $10 US per share.

Posted on 5-28-2014 at 7:21 AM
Tags: Allergan, Valeant Pharmaceuticals, Pharmaceuticals, Pershing Square

Valeant debt-loaded deal binge casts doubt on strategy

ANALYSIS: Valeant Pharmaceuticals International Inc.’s deal-fueled quest to become a $150 billion US company has some investors doubting the strategy as it loads up on debt.

Posted on 5-27-2014 at 7:50 AM
Tags: Valeant Pharmaceuticals, Allergan, Pharmaceuticals

Pfizer walks away from $118B AstraZeneca deal

Pfizer said on Monday it had abandoned its current attempt to buy AstraZeneca for nearly $118-billion as a deadline approached without a last-minute change of heart by the British drugmaker.

Posted on 5-26-2014 at 12:00 PM
Tags: Pharmaceuticals, Pfizer

AstraZeneca shareholder urges board back into talks with Pfizer

AstraZeneca's twelfth largest shareholder Schroders has joined a chorus of investor disapproval over its rejection of a takeover offer by Pfizer and urged it back into talks.

Posted on 5-20-2014 at 8:58 AM
Tags: Pfizer, Pharmaceuticals

Ackman says Allergan CEO has conflict of interest on takeover offer

Ackman and Montreal-based Valeant launched a $47-billion US takeover of the company on April 22, but Allergan rejected the offer on May 12 and has not budged since. Allergan Chief Executive Officer...

Posted on 5-19-2014 at 1:28 PM
Tags: Valeant Pharmaceuticals, Allergan, Pershing Square, Pharmaceuticals
Today's Guests CTV Two CTV News CTV News Channel BNN - Business News Network CP24